Nuedexta Often Used to Treat Symptoms of Parkinson’s and Dementia Off-label, Study Finds
An oral medicine approved to treat pseudobulbar affect — involuntary outbursts of laughing or crying — in people with amyotrophic lateral…
Articles by Iqra Mumal, MSc
New Collaboration Aims to Launch Parkinson’s Disease Research Into Space
Four organizations are teaming up with the goal of studying two neurodegenerative diseases — Parkinson’s disease and primary…
Dopaminergic Medication Lowers Patients’ Sensitivity to Negative Outcomes in Learning, Study Shows
Dopaminergic medication (i.e., levodopa) for Parkinson’s disease appears to bring sensitivity to negative outcomes in learning down to normal levels, a…
Participation of Early Parkinson’s Patients in Clinical Trials Crucial to Finding Cure, Expert Says
The time between diagnosis and implementation of symptomatic treatment is critical in the effort to find a cure for…
Non-Motor Symptoms During Wearing-off Periods Associated with Worse Quality of Life in Parkinson’s Patients
Parkinson’s patients with non-motor symptoms during “wearing-off” periods — when symptoms return as their medication wears off — have a…
Retinal Thinning Linked to Parkinson’s and Likely Disease Severity in Newly Diagnosed Patients, Study Finds
Thinning of the eye’s retina appears to be associated with Parkinson’s and, possibly, with disease severity, a study reports, suggesting that an…
Biomarkers Associated with Extreme Exhaustion in Cancer Also Linked to Fatigue in Parkinson’s, Study Says
Biomarkers responsible for extreme exhaustion in cancer patients are also associated with fatigue in Parkinson’s disease, a study reveals. The…
Aptinyx’s Investigational Parkinson’s Therapy NYX-458 Enters Phase 1 Clinical Testing
Aptinyx has launched a Phase 1 clinical trial of NYX-458, a potential treatment for cognitive impairment in…
8 or More Years of Contact Sports Linked to Parkinson’s-like Symptoms in Study
Athletes playing contact sports for longer than eight years are six times more likely to develop Lewy body disease —…
Chinese Compound Helps Reduce Levodopa-induced Dyskinesia, Eases Motor Symptoms in Parkinson’s, Study Finds
The traditional Chinese compound Zishenpingchan can be used as an add-on treatment to levodopa for improvements in motor symptoms and…